Eva Koetsier1, Glenn Franken2,3, Jacques Debets4, Sander M J van Kuijk5, Roberto S G M Perez6, Bengt Linderoth7, Elbert A J Joosten2,3, Paolo Maino1. 1. Pain Management Center, Neurocenter of Southern Switzerland, Regional Hospital of Lugano, Lugano, Switzerland. 2. Department of Anesthesiology and Pain Management, Maastricht University Medical Center+, Maastricht, The Netherlands. 3. Department of Translational Neuroscience, School of Mental Health and Neuroscience (MHeNS), University of Maastricht, Maastricht, The Netherlands. 4. Muroidean Facility, School of Cardiovascular Diseases (CARIM), Maastricht, The Netherlands. 5. Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, The Netherlands. 6. Department of Anesthesiology and Pain Management, VU University Medical Center, Amsterdam, The Netherlands. 7. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Abstract
AIMS: Conventional dorsal root ganglion stimulation (DRGS) is known to achieve better pain-paresthesia overlap of difficult-to-reach areas like the feet compared to dorsal column spinal cord stimulation (SCS). As in painful diabetic polyneuropathy (PDPN) pain is mostly present in the feet, we hypothesized that DRGS is more effective in relieving pain in PDPN when compared to SCS. METHODS: Diabetes was induced in female Sprague-Dawley rats with an intraperitoneal injection of 65 mg/kg of streptozotocin (STZ; n = 48). Rats with a significant decrease in mechanical paw withdrawal response to von Frey filaments 4 weeks after injection were implanted with DRGS electrodes (n = 18). Rats were assigned to DRGS (n = 11) or sham-DRGS (n = 7). Mechanical paw withdrawal thresholds (WT, measured in grams) in response to DRGS (50 Hz, 0.18 ± 0.05 mA) were assessed with von Frey testing. The results of the experiments on these animals were compared to the results of a previous study using exactly the same model on PDPN animals selected for SCS (n = 8) (40-50 Hz, 0.19 ± 0.01 mA) and sham-SCS (n = 3). RESULTS: In the SCS group, the log10 (10 000 × 50% WT) increased from 4910 to 5211 at t = 15 minutes (P < 0.05) and 5264 at t = 30 minutes (P = 0.11). In the DRGS group, the log10 (10,000 × 50% WT) increased from 4376 to 4809 at t = 15 minutes (P < 0.01) and 5042 at t = 30 minutes (P < 0.01). Both DRGS and SCS induced a similar and complete reversal of mechanical hypersensitivity. After cessation of stimulation (t = 60), the return of the log10 (10 000 × 50% WT) response was significantly faster with DRGS than that of SCS (P < 0.05). CONCLUSIONS: We conclude that conventional DRGS is as effective as SCS in reduction of PDPN-associated mechanical hypersensitivity in STZ-induced diabetic rats. The wash-in effect of DRGS and SCS was similar, but DRGS showed a faster washout course. Long-term efficacy should be studied in future animal research.
AIMS: Conventional dorsal root ganglion stimulation (DRGS) is known to achieve better pain-paresthesia overlap of difficult-to-reach areas like the feet compared to dorsal column spinal cord stimulation (SCS). As in painful diabetic polyneuropathy (PDPN) pain is mostly present in the feet, we hypothesized that DRGS is more effective in relieving pain in PDPN when compared to SCS. METHODS:Diabetes was induced in female Sprague-Dawley rats with an intraperitoneal injection of 65 mg/kg of streptozotocin (STZ; n = 48). Rats with a significant decrease in mechanical paw withdrawal response to von Frey filaments 4 weeks after injection were implanted with DRGS electrodes (n = 18). Rats were assigned to DRGS (n = 11) or sham-DRGS (n = 7). Mechanical paw withdrawal thresholds (WT, measured in grams) in response to DRGS (50 Hz, 0.18 ± 0.05 mA) were assessed with von Frey testing. The results of the experiments on these animals were compared to the results of a previous study using exactly the same model on PDPN animals selected for SCS (n = 8) (40-50 Hz, 0.19 ± 0.01 mA) and sham-SCS (n = 3). RESULTS: In the SCS group, the log10 (10 000 × 50% WT) increased from 4910 to 5211 at t = 15 minutes (P < 0.05) and 5264 at t = 30 minutes (P = 0.11). In the DRGS group, the log10 (10,000 × 50% WT) increased from 4376 to 4809 at t = 15 minutes (P < 0.01) and 5042 at t = 30 minutes (P < 0.01). Both DRGS and SCS induced a similar and complete reversal of mechanical hypersensitivity. After cessation of stimulation (t = 60), the return of the log10 (10 000 × 50% WT) response was significantly faster with DRGS than that of SCS (P < 0.05). CONCLUSIONS: We conclude that conventional DRGS is as effective as SCS in reduction of PDPN-associated mechanical hypersensitivity inSTZ-induced diabeticrats. The wash-in effect of DRGS and SCS was similar, but DRGS showed a faster washout course. Long-term efficacy should be studied in future animal research.
Authors: Anthony M Rush; Sulayman D Dib-Hajj; Shujun Liu; Theodore R Cummins; Joel A Black; Stephen G Waxman Journal: Proc Natl Acad Sci U S A Date: 2006-05-15 Impact factor: 11.205
Authors: Cecile C de Vos; Kaare Meier; Paul Brocades Zaalberg; Harold J A Nijhuis; Wim Duyvendak; Jan Vesper; Thomas P Enggaard; Mathieu W P M Lenders Journal: Pain Date: 2014-08-29 Impact factor: 6.961
Authors: W A Pluijms; R Slangen; M Bakkers; C G Faber; I S J Merkies; A G Kessels; C D Dirksen; E A Joosten; J P H Reulen; R T van Dongen; N C Schaper; M van Kleef Journal: Br J Anaesth Date: 2012-08-14 Impact factor: 9.166
Authors: Sam Eldabe; Anthony Espinet; Anders Wahlstedt; Porhan Kang; Liong Liem; Nikunj K Patel; Jan Vesper; Alicia Kimber; William Cusack; Jeffery Kramer Journal: Neuromodulation Date: 2018-03-25
Authors: Eva Koetsier; Glenn Franken; Jacques Debets; Sander M J van Kuijk; Roberto S G M Perez; Bengt Linderoth; Elbert A J Joosten; Paolo Maino Journal: CNS Neurosci Ther Date: 2018-09-23 Impact factor: 5.243
Authors: Eva Koetsier; Glenn Franken; Jacques Debets; Lonne Heijmans; Sander M J van Kuijk; Bengt Linderoth; Elbert A Joosten; Paolo Maino Journal: CNS Neurosci Ther Date: 2019-07-23 Impact factor: 5.243